The A2 Milk (ASX:A2M) share price is up 17% in the last month, here's why

The Kiwi dairy producer has given plenty of headaches for investors, but the stock seems to have turned around recently.

| More on:
Young girl drinking milk showing off muscles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A2 Milk Company Ltd (ASX: A2M) shares have gone gangbusters in the past month, rising more than 16.6%.

But of course, that's after its investors cried over much spilt milk in the past year. The stock has lost more than 63% in the past 12 months.

This month has seen the agricultural stock become one of the most traded among Australian investors, with it involved in 2.1% of all transactions on CommSec last week.

Pleasingly, buyers accounted for 71% of that volume.

So what's with the July revival?

Acquisition about to complete

A2 Milk's proposed majority-acquisition of Mataura Valley Milk will complete by the end of this month.

That follows a 5 July blessing from the New Zealand Overseas Investment Office, which sent the shares rocketing up.

"Management expects the acquisition to provide the opportunity for a2 Milk to participate in nutritional products manufacturing, provide supplier and geographic diversification, and strengthen its relationship with key partners in China," reported The Motley Fool's James Mickleboro at the time.

Analysts warming to A2 Milk

Fund managers are starting to take notice of A2 Milk, with some arguing the stock has been oversold.

Bell Potter senior industrial analyst Jonathan Snape said last week that the business was absolutely flying before COVID-19 took hold last year.

So A2 Milk could be a nice pandemic recovery story.

"While not without near-term risks as supply chains stabilise, at its core we see A2M as a business that, once [margin] is consolidated, has baseline revenue of ~NZ$1.4 to $1.5 billion and EBITDA of ~NZ$300m," he said in a memo to clients.

Snape can see A2 Milk hitting NZ$1.7 billion in revenue with NZ$445 million EBITDA.

Watermark portfolio manager Daniel Broeren posted on Livewire that the A2 Platinum formula brand continues to be popular with Chinese mothers.

"While there are some risks around market size (declining birth rate), and recovery timeline for Chinese travellers (daigou), these are palatable risks when the stock is trading at such a significant discount to prior valuations."

Still plenty of short interest on A2 Milk 

While the discounted share price has won over some fans, there are still plenty of sceptics.

Last week, The Motley Fool reported A2 Milk shares had re-entered the top 10 most shorted stocks on the ASX.

About 6.8% of its shares have been shorted, on the back of worries about the still-depressed daigou sales channel and the competition from Chinese baby formula makers.

Motley Fool contributor Tony Yoo owns shares of A2 Milk. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was another woeful day for investors this Wednesday.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Cedar Woods, Humm, Star, and Zip shares are storming higher today

These shares are having a better day than most on hump day. But why?

Read more »

bull market model with a bull looking at a rising chart
Opinions

By December 2026, $1,000 invested in EOS shares could be worth…

With its share price taking off and contracts piling up, EOS is shaping up as one of the most compelling…

Read more »

Army man and woman on digital devices.
Share Gainers

Guess which ASX 300 defence stock has already rocketed 51% this week (Hint, not DroneShield)

Investors have sent this ASX 300 defence stock flying this week. But why?

Read more »